구제역(FMD) 백신 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Foot and Mouth Disease Vaccine Market (Type: Aluminum Hydroxide and Saponin Vaccines and Oil-based Vaccines; and Animal: Cattle, Sheep and Goat, Swine/Pig, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

US $ 5,795 ￦ 8,384,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795 ￦ 12,725,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795 ￦ 17,066,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

구제역(FMD) 백신 시장 - 보고서의 범위

세계 구제역(FMD) 백신 시장에 대한 TMR의 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 세계 구제역(FMD) 백신 시장의 수익을 제공합니다. 2023년을 기준 연도로, 2031년을 예측 연도로 간주하여 2017-2031년 기간 동안 구강 질환 백신 시장을 분석합니다. 이 보고서는 또한 2023-2031년간 세계 구제역(FMD) 백신 시장의 복합 연간 성장률(CAGR%)을 제공합니다.

이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서는 분석가들이 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하여 주요 조사 활동의 대부분을 수행했으며, 2차 조사에서는 주요 기업의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서에 대한 참조를 통해 구제역(FMD) 백신 시장을 파악했습니다.

이 보고서는 세계 구제역(FMD) 백신 시장 경쟁 구도를 자세히 분석합니다. 세계 구제역(FMD) 백신 시장에서 활동하는 주요 기업이 식별되며, 이들 각각은 다양한 속성 측면에서 프로파일링됩니다. 기업 프로파일, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 구제역(FMD) 백신 시장 기업의 속성입니다.

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

• 서론
• 개요
• 시장 역학
• 세계 시장 분석과 예측, 2017-2031년

제5장 주요 인사이트

• 구제역 개요
• 질병 유병률과 발생률 개요
• 규제 시나리오
• 주요 업계 이벤트
• COVID-19 팬데믹의 업계에 대한 영향(밸류체인과 단기/중기/장기적인 영향)

제6장 세계 시장 분석과 예측 : 유형별

• 서론과 정의
• 주요 발견/개발
• 시장 매출 예측 : 유형별, 2017-2031
  • 수산화 알루미늄과 사포닌 백신
  • 석유 기반 백신
    • Single-oil Emulsion
    • Double-oil Emulsion
• 시장의 매력 : 유형별

제7장 세계 시장 분석과 예측 : 동물별

• 서론과 정의
• 주요 발견/개발
• 시장 매출 예측 : 동물별, 2017-2031
  • 소
  • 양 및 염소
  • 돼지(Swine/Pig)
  • 기타
• 시장의 매력 : 동물별

제8장 세계 시장 분석과 예측 : 유통 채널별

• 서론과 정의
• 주요 발견/개발
• 시장 매출 예측 : 유통 채널별, 2017-2031
  • 동물병원
  • 정부기관
  • 기타
• 시장의 매력 : 유통 채널별

제9장 세계 시장 분석과 예측 : 지역별

• 주요 조사 결과
• 시장 매출 예측 : 지역별
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
  • 세계 기타 지역
• 시장의 매력 : 국가 및 지역별

제10장 아시아태평양 시장 분석과 예측

제11장 라틴아메리카 시장 분석과 예측

제12장 중동 및 아프리카 시장 분석과 예측

제13장 세계 기타 지역 시장 분석과 예측

제14장 경쟁 구도

• 시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
• 기업 개요
  • BVI
  • Indian Immunologicals Ltd.
  • Ceva Sante Animale
  • MEVAC
  • National Veterinary Institute
  • Limor de Colombia SAS
  • Brilliant Bio Pharma
  • Biogenesis Bago
  • Kenya Veterinary Vaccines Production Institute
  • Boehringer Ingelheim International GmbH
  • Zoetis, Inc.
  • Ourofino Saude Animal

LSH

영문 목차

영문목차

Foot and Mouth Disease Vaccine Market - Scope of Report

TMR's report on the global Foot and Mouth Disease Vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Foot and Mouth Disease Vaccine market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Foot and Mouth Disease Vaccine market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Foot and Mouth Disease Vaccine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Foot and Mouth Disease Vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Foot and Mouth Disease Vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Foot and Mouth Disease Vaccine market.

The report delves into the competitive landscape of the global Foot and Mouth Disease Vaccine market. Key players operating in the global Foot and Mouth Disease Vaccine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Foot and Mouth Disease Vaccine market profiled in this report.

Key Questions Answered in Global Foot and Mouth Disease Vaccine Market Report:

• What is the sales/revenue generated by Foot and Mouth Disease Vaccine across all regions during the forecast period?
• What are the opportunities in the global Foot and Mouth Disease Vaccine market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Foot and Mouth Disease Vaccine Market - Research Objectives and Research Approach

The comprehensive report on the global Foot and Mouth Disease Vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Foot and Mouth Disease Vaccine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Foot and Mouth Disease Vaccine market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Foot and Mouth Disease Vaccine Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Foot and Mouth Disease Overview
• 5.2. Disease Prevalence & Incidence Rate Overview
• 5.3. Regulatory Scenario
• 5.4. Key Industry Events
• 5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

6. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Type, 2017-2031
  • 6.3.1. Aluminum Hydroxide and Saponin Vaccines
  • 6.3.2. Oil-based Vaccines
    • 6.3.2.1. Single-oil Emulsion
    • 6.3.2.2. Double-oil Emulsion
• 6.4. Market Attractiveness, by Type

7. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Animal

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Animal, 2017-2031
  • 7.3.1. Cattle
  • 7.3.2. Sheep and Goat
  • 7.3.3. Swine/Pig
  • 7.3.4. Others
• 7.4. Market Attractiveness, by Animal

8. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Distribution Channel

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
  • 8.3.1. Veterinary Clinics
  • 8.3.2. Government Institutions
  • 8.3.3. Others
• 8.4. Market Attractiveness, by Distribution Channel

9. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region
  • 9.2.1. Asia Pacific
  • 9.2.2. Latin America
  • 9.2.3. Middle East & Africa
  • 9.2.4. Rest of the World
• 9.3. Market Attractiveness, by Country/Region

10. Asia Pacific Foot and Mouth Disease Vaccine Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Type, 2017-2031
  • 10.2.1. Aluminum Hydroxide and Saponin Vaccines
  • 10.2.2. Oil-based Vaccines
    • 10.2.2.1. Single-oil Emulsion
    • 10.2.2.2. Double-oil Emulsion
• 10.3. Market Value Forecast, by Animal, 2017-2031
  • 10.3.1. Cattle
  • 10.3.2. Sheep and Goat
  • 10.3.3. Swine/Pig
  • 10.3.4. Others
• 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
  • 10.4.1. Veterinary Clinics
  • 10.4.2. Government Institutions
  • 10.4.3. Others
• 10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 10.5.1. China
  • 10.5.2. India
  • 10.5.3. Rest of Asia Pacific
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Type
  • 10.6.2. By Animal
  • 10.6.3. By Distribution Channel
  • 10.6.4. By Country/Sub-region

11. Latin America Foot and Mouth Disease Vaccine Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Type, 2017-2031
  • 11.2.1. Aluminum Hydroxide and Saponin Vaccines
  • 11.2.2. Oil-based Vaccines
    • 11.2.2.1. Single-oil Emulsion
    • 11.2.2.2. Double-oil Emulsion
• 11.3. Market Value Forecast, by Animal, 2017-2031
  • 11.3.1. Cattle
  • 11.3.2. Sheep and Goat
  • 11.3.3. Swine/Pig
  • 11.3.4. Others
• 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
  • 11.4.1. Veterinary Clinics
  • 11.4.2. Government Institutions
  • 11.4.3. Others
• 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.5.1. Brazil
  • 11.5.2. Argentina
  • 11.5.3. Rest of Latin America
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Type
  • 11.6.2. By Animal
  • 11.6.3. By Distribution Channel
  • 11.6.4. By Country/Sub-region

12. Middle East & Africa Foot and Mouth Disease Vaccine Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Type, 2017-2031
  • 12.2.1. Aluminum Hydroxide and Saponin Vaccines
  • 12.2.2. Oil-based Vaccines
    • 12.2.2.1. Single-oil Emulsion
    • 12.2.2.2. Double-oil Emulsion
• 12.3. Market Value Forecast, by Animal, 2017-2031
  • 12.3.1. Cattle
  • 12.3.2. Sheep and Goat
  • 12.3.3. Swine/Pig
  • 12.3.4. Others
• 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
  • 12.4.1. Veterinary Clinics
  • 12.4.2. Government Institutions
  • 12.4.3. Others
• 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.5.1. GCC Countries
  • 12.5.2. South Africa
  • 12.5.3. Rest of Middle East & Africa
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Type
  • 12.6.2. By Animal
  • 12.6.3. By Distribution Channel
  • 12.6.4. By Country/Sub-region

13. Rest of the World Foot and Mouth Disease Vaccine Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Type, 2017-2031
  • 13.2.1. Aluminum Hydroxide and Saponin Vaccines
  • 13.2.2. Oil-based Vaccines
    • 13.2.2.1. Single-oil Emulsion
    • 13.2.2.2. Double-oil Emulsion
• 13.3. Market Value Forecast, by Animal, 2017-2031
  • 13.3.1. Cattle
  • 13.3.2. Sheep and Goat
  • 13.3.3. Swine/Pig
  • 13.3.4. Others
• 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
  • 13.4.1. Veterinary Clinics
  • 13.4.2. Government Institutions
  • 13.4.3. Others
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Type
  • 13.5.2. By Animal
  • 13.5.3. By Distribution Channel

14. Competition Landscape

• 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 14.2. Company Profiles
  • 14.2.1. BVI
    • 14.2.1.1. Company Overview
    • 14.2.1.2. Financial Overview
    • 14.2.1.3. Product Portfolio
    • 14.2.1.4. Business Strategies
    • 14.2.1.5. Recent Developments
  • 14.2.2. Indian Immunologicals Ltd.
    • 14.2.2.1. Company Overview
    • 14.2.2.2. Financial Overview
    • 14.2.2.3. Product Portfolio
    • 14.2.2.4. Business Strategies
    • 14.2.2.5. Recent Developments
  • 14.2.3. Ceva Sante Animale
    • 14.2.3.1. Company Overview
    • 14.2.3.2. Financial Overview
    • 14.2.3.3. Product Portfolio
    • 14.2.3.4. Business Strategies
    • 14.2.3.5. Recent Developments
  • 14.2.4. MEVAC
    • 14.2.4.1. Company Overview
    • 14.2.4.2. Financial Overview
    • 14.2.4.3. Product Portfolio
    • 14.2.4.4. Business Strategies
    • 14.2.4.5. Recent Developments
  • 14.2.5. National Veterinary Institute
    • 14.2.5.1. Company Overview
    • 14.2.5.2. Financial Overview
    • 14.2.5.3. Product Portfolio
    • 14.2.5.4. Business Strategies
    • 14.2.5.5. Recent Developments
  • 14.2.6. Limor de Colombia SAS
    • 14.2.6.1. Company Overview
    • 14.2.6.2. Financial Overview
    • 14.2.6.3. Product Portfolio
    • 14.2.6.4. Business Strategies
    • 14.2.6.5. Recent Developments
  • 14.2.7. Brilliant Bio Pharma
    • 14.2.7.1. Company Overview
    • 14.2.7.2. Financial Overview
    • 14.2.7.3. Product Portfolio
    • 14.2.7.4. Business Strategies
    • 14.2.7.5. Recent Developments
  • 14.2.8. VETAL Animal Health Products, Inc.
    • 14.2.8.1. Company Overview
    • 14.2.8.2. Financial Overview
    • 14.2.8.3. Product Portfolio
    • 14.2.8.4. Business Strategies
    • 14.2.8.5. Recent Developments
  • 14.2.9. Biogenesis Bago
    • 14.2.9.1. Company Overview
    • 14.2.9.2. Financial Overview
    • 14.2.9.3. Product Portfolio
    • 14.2.9.4. Business Strategies
    • 14.2.9.5. Recent Developments
  • 14.2.10. Kenya Veterinary Vaccines Production Institute
    • 14.2.10.1. Company Overview
    • 14.2.10.2. Financial Overview
    • 14.2.10.3. Product Portfolio
    • 14.2.10.4. Business Strategies
    • 14.2.10.5. Recent Developments
  • 14.2.11. Boehringer Ingelheim International GmbH
    • 14.2.11.1. Company Overview
    • 14.2.11.2. Financial Overview
    • 14.2.11.3. Product Portfolio
    • 14.2.11.4. Business Strategies
    • 14.2.11.5. Recent Developments
  • 14.2.12. Zoetis, Inc.
    • 14.2.12.1. Company Overview
    • 14.2.12.2. Financial Overview
    • 14.2.12.3. Product Portfolio
    • 14.2.12.4. Business Strategies
    • 14.2.12.5. Recent Developments
  • 14.2.13. Ourofino Saude Animal
    • 14.2.13.1. Company Overview
    • 14.2.13.2. Financial Overview
    • 14.2.13.3. Product Portfolio
    • 14.2.13.4. Business Strategies
    • 14.2.13.5. Recent Developments

관련자료